13 unknown. 13 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Unknown 13 |
| Phase 1 | 3 | Unknown 3 |
| Phase 3 | 1 | Unknown 1 |
Follow Pleural Effusion: new trials by email Literature Review of Pleural Effusion trials Research Report on Pleural Effusion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Intrapleural Administration of Bevacizumab and Camrelizumab for Malignant Pleural Effusion bevacizumab and camrelizumab - Malignant Pleural Effusion | Phase 1 / Phase 2 | Unknown | The First Affiliated Hospital of Zhengzhou University | 55 | 2022-08-01 | 2022-04-15 |
| A Study of Syngenon (BSG-001) for Inhalation in Subjects With Malignant Pleural Effusion and/or Malignant Ascites BSG-001 - Malignant Pleural Effusion, Malignant Ascites | Phase 1 / Phase 2 | Unknown | BioSyngen Pte Ltd | 58 | 2019-01-01 | 2018-11-08 |
| Management of Malignant Pleural Effusion With Indwelling Pleural Catheter Versus Silver Nitrate Pleurodesis Silver Nitrate, Indwelling Pleural Catheter - Pleural Effusion, Malignant | Phase 1 / Phase 2 | Unknown | Assiut University | 50 | 2019-01-01 | 2018-12-20 |
| A Randomized Study of Primary Tumor Radiotherapy for Patients With MPE Stage IV NSCLC Radiation, Chemotherapy - Malignant Pleural Effusion, Nonsmall Cell Lung Cancer, Stage IV | Phase 2 | Unknown | Guizhou Medical University | 68 | 2018-09-01 | 2019-06-14 |
| Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer Bevacizumab - Malignant Pleural Effusion | Phase 2 | Unknown | Peking University Cancer Hospital & Institute | 87 | 2016-10-01 | 2018-11-07 |
| Clinical Trial of Tumor Cell-derived Microparticles Packaging Chemotherapeutic Drugs to Treat Malignant Pleural Effusion tumor derived microparticles, cisplatin - Malignant Pleural Effusion | Phase 2 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 90 | 2016-01-01 | 2019-02-26 |
| Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion rAdp53, Cisplatin, rAdp53 plus cisplatin - Malignant Pleural Effusion | Phase 2 | Unknown | Shenzhen SiBiono GeneTech Co.,Ltd | 90 | 2015-06-01 | 2015-04-29 |
| Safety and Effectiveness Study of Tumor Cell-derived Microparticles to Treat Malignant Ascites and Pleural Effusion Drug-packaging microparticles - Malignant Pleural Effusion,, Malignant Ascites | Phase 2 | Unknown | Huazhong University of Science and Technology | 30 | 2013-05-01 | 2013-10-01 |
| Efficacy and Safety of Bevacizumab Versus Pulvis Talci in Malignant Pleural Effusion Bevacizumab, Pulvis talci - Malignant Pleural Effusion | Phase 2 | Unknown | Tang-Du Hospital | 183 | 2012-01-01 | 2014-02-04 |
| Effectiveness of Doxycycline for Treating Pleural Effusions Related to Cancer in an Outpatient Population Doxycycline, normal saline - Malignant Pleural Effusion | Phase 2 | Unknown | Ottawa Hospital Research Institute | 40 | 2011-06-01 | 2020-09-25 |
| Safety and Effectiveness Study for Pleurodesis With Silver Nitrate in Malignant Pleural Effusion Silver Nitrate - Malignant Pleural Effusion | Phase 2 | Unknown | University of Sao Paulo General Hospital | 60 | 2009-08-01 | 2010-05-18 |
| Dornase Alfa and Urokinase for Kids With Pleural Empyema Urokinase and Dornase alfa, Urokinase - Pleural Empyema | Phase 2 / Phase 3 | Unknown | Azienda Ospedaliera di Padova | 94 | 2007-10-01 | 2008-05-12 |
| Ibuprofen or Morphine in Treating Pain in Patients Undergoing Pleurodesis for Malignant Pleural Effusion ibuprofen, morphine sulfate, management of therapy complications - Metastatic Cancer | Phase 2 | Unknown | Oxford University Hospitals NHS Trust | 320 | 2007-03-01 | 2009-07-08 |
Pleural Effusion, Malignant (12) · Ascites (1) · Carcinoma, Non-Small-Cell Lung (1) · Empyema, Pleural (1) · Neoplasm Metastasis (1) · Pain (1)
Pleural Diseases (13) · Respiratory Tract Diseases (13) · Neoplasms (12) · Neoplasms by Site (12) · Pleural Neoplasms (12) · Respiratory Tract Neoplasms (12) · Thoracic Neoplasms (12) · Pathological Conditions, Signs and Symptoms (4) · Pathologic Processes (3) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Empyema (1) · Infections (1) · Inflammation (1)
Bevacizumab (3) · Cisplatin (2) · Silver Nitrate (2) · Doxycycline (1) · Drug Therapy (1) · Ibuprofen (1) · Morphine (1) · Pleurodesis (1) · Radiation (1) · Saline Solution (1) · Urokinase-Type Plasminogen Activator (1) · camrelizumab (1) · dornase alfa (1)
Assiut University (1) · Azienda Ospedaliera di Padova (1) · BioSyngen Pte Ltd (1) · Guizhou Medical University (1) · Huazhong University of Science and Technology (1) · Ottawa Hospital Research Institute (1) · Oxford University Hospitals NHS Trust (1) · Peking University Cancer Hospital & Institute (1) · Shenzhen SiBiono GeneTech Co.,Ltd (1) · Tang-Du Hospital (1) · The First Affiliated Hospital of Zhengzhou University (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) · University of Sao Paulo General Hospital (1)
China (6) · Australia (1) · Brazil (1) · Canada (1) · Italy (1) · United Kingdom (1)
Bo Huang, Ph.D (1) · Feng Wang (1) · Giorgio Stefanutti, MD (1) · Jian Fang (1) · K. Amjadi, MD, FRCPC (1) · Lietao Li, MD (1) · PierGiorgio Gamba, MD (1) · Ricardo M Terra, MD (1) · Robert Davies, MD (1) · Yang Jin, doctor (1)
PMID 16107633, PMID 16111068, PMID 16790519, PMID 16797681, PMID 16940982, PMID 18561992, PMID 18710781, PMID 21267391, PMID 22083202, PMID 23178954, PMID 23925664, PMID 25798278, PMID 35080187